Yes, CGMP rules ensure pure & stable drug samples. Yes, rigorous study designs make study results more credible. The question is: how much more credible, relative to the cost?
-
-
If this “works” for generating drugs or vaccines that actually work, faster or cheaper than average, then we’ll know that there can be value in streamlining these processes.
Show this threadThanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
What do you think of my "Competing FDAs" proposal (In my reply to the On Building essay)? I was thinking of fleshing it out a bit more
-
Haven’t read it but yes this.
- 1 more reply
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.